Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage

Arthritis Care and Research

Volumn 66, Issue 2, 2014, Pages 301-310

  Cartin Ceba, Rodrigo ^a   Peikert, Tobias ^a   Ashrani, Aneel ^a   Keogh, Karina ^a   Wylam, Mark E ^a   Ytterberg, Steven ^a   Specks, Ulrich ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GLUCOCORTICOID; HEMOSIDERIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ADULT; ANTIPHOSPHOLIPID SYNDROME; CAPILLARITIS; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFUSE ALVEOLAR HEMORRHAGE; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; LUNG BIOPSY; LUNG HEMORRHAGE; LUNG INFILTRATE; LUNG LAVAGE; MACROPHAGE; MALE; MIDDLE AGED; NEUTROPHIL; PLASMAPHERESIS; PROGNOSIS; REMISSION; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARIES; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES; MALE; MIDDLE AGED; MINNESOTA; PULMONARY ALVEOLI; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893376870     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22109     Document Type: Review

References (41)

1. Krause ML, Cartin-Ceba R, Specks U, Peikert T,. Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin North Am 2012; 32: 587-600.
2. Lara AR, Schwarz MI,. Diffuse alveolar hemorrhage. Chest 2010; 137: 1164-71.
3. Lee AS, Specks U,. Pulmonary capillaritis. Semin Respir Crit Care Med 2004; 25: 547-55.
4. Specks U,. Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol 2001; 13: 12-7.
5. Al-Hajjaj MS,. Massive pulmonary hemorrhage in a Saudi female with primary antiphospholipid syndrome. Saudi Med J 2000; 21: 777-9.
6. Crausman RS, Achenbach GA, Pluss WT, O'Brien RF, Jennings CA,. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol 1995; 22: 554-6.
7. Deane KD, West SG,. Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review. Semin Arthritis Rheum 2005; 35: 154-65.
8. Gertner E,. Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment. J Rheumatol 1999; 26: 805-7.
9. Gertner E, Lie JT,. Pulmonary capillaritis, alveolar hemorrhage, and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol 1993; 20: 1224-8.
10. Hillerdal G, Hagg A, Licke G, Wegenius G, Scheibenpflug L,. Intra-alveolar haemorrhage in the anticardiolipin antibody syndrome. Scand J Rheumatol 1991; 20: 58-62.
11. Lafosse-Marin M, Marcq M, Diot P, Gruel Y, Diot E,. Intra-alveolar pulmonary haemorrhage, an unusual manifestation of the primary antiphospholipid syndrome. Rev Med Interne 2009; 30: 271-3. In French.
12. Marcos Rodriguez PJ, Montero Martinez C, Verea Hernando H,. Pulmonary haemorrhage and primary antiphospholipid syndrome: case report and review. An Med Interna 2007; 24: 125-8. In Spanish.
13. Martinez-Vazquez C, Perez S, Bordon J, Ordi-Ros J, Ribera A, Lopez A,. Pulmonary hemorrhage and anti-phospholipid syndrome. Rev Clin Esp 2004; 204: 528-31. In Spanish.
14. Scheiman Elazary A, Klahr PP, Hershko AY, Dranitzki Z, Rubinow A, Naparstek Y,. Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome. Lupus 2012; 21: 438-40.
15. Suzuki A, Asazuma N, Kikuchi E, Kawanobe T, Horimoto Y, Yokobari R, et al. "Possible primary antiphospholipid syndrome" with concurrent diffuse alveolar hemorrhaging and Libman-Sacks endocarditis mimicking catastrophic antiphospholipid syndrome. Intern Med 2012; 51: 813-6.
16. Waterer GW, Latham B, Waring JA, Gabbay E,. Pulmonary capillaritis associated with the antiphospholipid antibody syndrome and rapid response to plasmapheresis. Respirology 1999; 4: 405-8.
17. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-11.
18. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
19. Jeffrey PJ, Asherson RA, Rees PJ,. Recurrent deep vein thrombosis, thromboembolic pulmonary hypertension and the 'primary' antiphospholipid syndrome. Clin Exp Rheumatol 1989; 7: 567-9.
20. Anderson NE, Ali MR,. The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension. Ann Rheum Dis 1984; 43: 760-3.
21. Luchi ME, Asherson RA, Lahita RG,. Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis: association with antiphospholipid antibodies. Arthritis Rheum 1992; 35: 700-5.
22. Asherson RA, Cervera R,. Catastrophic antiphospholipid syndrome. Curr Opin Hematol 2000; 7: 325-9.
23. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530-4.
24. Espinosa G, Cervera R, Font J, Asherson RA,. The lung in the antiphospholipid syndrome. Ann Rheum Dis 2002; 61: 195-8.
25. Ford HJ, Roubey RA,. Pulmonary manifestations of the antiphospholipid antibody syndrome. Clin Chest Med 2010; 31: 537-45.
26. Asherson RA, Greenblatt MA,. Recurrent alveolar hemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome. J Clin Rheumatol 2001; 7: 30-3.
27. Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D, et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003; 112: 1644-54.
28. Bucciarelli S, Espinosa G, Asherson RA, Cervera R, Claver G, Gomez-Puerta JA, et al. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 2006; 65: 81-6.
29. Cuchacovich R, Espinoza LR,. Is antiphospholipid antibody determination clinically relevant to the vasculitides? Semin Arthritis Rheum 2001; 31: 1-3.
30. Aron AL, Gharavi AE, Shoenfeld Y,. Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. Int Arch Allergy Immunol 1995; 106: 8-12.
31. Garcia CO, Kanbour-Shakir A, Tang H, Molina JF, Espinoza LR, Gharavi AE,. Induction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with β 2 GPI. Am J Reprod Immunol 1997; 37: 118-24.
32. George J, Blank M, Levy Y, Meroni P, Damianovich M, Tincani A, et al. Differential effects of anti-β2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 1998; 97: 900-6.
33. 2- glycoprotein I and induce endothelial activation. Arthritis Rheum 1997; 40: 551-61.
34. Lie JT,. Vasculitis in the antiphospholipid syndrome: culprit or consort? J Rheumatol 1994; 21: 397-9.
35. Chakravarty K, Pountain G, Merry P, Byron M, Hazleman B, Scott DG,. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1995; 22: 1694-7.
36. Duhaut P, Berruyer M, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, et al, for the Groupe de Recherche sur l'Arterite a Cellules Geantes. Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Arthritis Rheum 1998; 41: 701-9.
37. Espinoza LR, Jara LJ, Silveira LH, Martinez-Osuna P, Zwolinska JB, Kneer C, et al. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. Am J Med 1991; 90: 474-8.
38. Seriolo B, Accardo S, Cutolo M,. Lipoprotein(a) and anticardiolipin antibodies as risk factors for thrombotic events in polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1996; 23: 1478-80.
39. Hashimoto N, Iwasaki T, Sekiguchi M, Takatsuka H, Okamoto T, Hashimoto T, et al. Autologous hematopoietic stem cell transplantation for refractory antiphospholipid syndrome causing myocardial necrosis. Bone Marrow Transplant 2004; 33: 863-6.
40. Statkute L, Traynor A, Oyama Y, Yaung K, Verda L, Krosnjar N, et al. Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation. Blood 2005; 106: 2700-9.
41. Owaidah TM, Maghrabi K, Elkarouri MA, Al Mohareeb F, Al Harthi A, Al Zahrani H,. Successful treatment of a case of catastrophic antiphospholipid syndrome with autologous BMT: case report and review of literature. Bone Marrow Transplant 2011; 46: 597-600.